Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Satoh

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
The Journal of Applied Laboratory Medicine|March 4, 2022
Correction to: The International Consensus on ANA Patterns (ICAP) in 2021-the 6th Workshop and Current PerspectivesEdward K L Chan, Carlos A von Mühlen, Marvin J Fritzler, et al.
BMC Rheumatology|February 16, 2022
Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case reportFlavie Roy, Pat Korathanakhun, Jason Karamchandani, et al.
Immunologic Research|October 9, 2021
How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiativeCarlos Alberto von Mühlen, Ignacio Garcia-De La Torre, Maria Infantino, et al.
Autoimmunity Reviews|August 26, 2024
Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshopLuis E C Andrade, Werner Klotz, Manfred Herold, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Arthritis and Rheumatism|January 13, 2012
Prevalence and sociodemographic correlates of antinuclear antibodies in the United StatesMinoru Satoh, Edward K L Chan, Lindsey A Ho, et al.
RMD Open|September 6, 2020
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodiesOcéane Landon-Cardinal, Alexandra Baril-Dionne, Sabrina Hoa, et al.
Neuromuscular Disorders : NMD|January 17, 2023
Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositisAlain Meyer, Yves Troyanov, Pat Korathanakhun, et al.
Arthritis Research & Therapy|April 6, 2013
Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and GuadalajaraMarcelo H Petri, Minoru Satoh, Beatriz T Martin-Marquez, et al.
Annals of the Rheumatic Diseases|May 14, 2026
International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseasesRoko P A Nikolic, Eldad Ben-Chetrit, Marvin J Fritzler, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
The Journal of Applied Laboratory Medicine|March 4, 2022
Correction to: The International Consensus on ANA Patterns (ICAP) in 2021-the 6th Workshop and Current PerspectivesEdward K L Chan, Carlos A von Mühlen, Marvin J Fritzler, et al.
BMC Rheumatology|February 16, 2022
Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case reportFlavie Roy, Pat Korathanakhun, Jason Karamchandani, et al.
Immunologic Research|October 9, 2021
How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiativeCarlos Alberto von Mühlen, Ignacio Garcia-De La Torre, Maria Infantino, et al.
Autoimmunity Reviews|August 26, 2024
Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshopLuis E C Andrade, Werner Klotz, Manfred Herold, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Arthritis and Rheumatism|January 13, 2012
Prevalence and sociodemographic correlates of antinuclear antibodies in the United StatesMinoru Satoh, Edward K L Chan, Lindsey A Ho, et al.
RMD Open|September 6, 2020
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodiesOcéane Landon-Cardinal, Alexandra Baril-Dionne, Sabrina Hoa, et al.
Neuromuscular Disorders : NMD|January 17, 2023
Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositisAlain Meyer, Yves Troyanov, Pat Korathanakhun, et al.
Arthritis Research & Therapy|April 6, 2013
Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and GuadalajaraMarcelo H Petri, Minoru Satoh, Beatriz T Martin-Marquez, et al.
Annals of the Rheumatic Diseases|May 14, 2026
International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseasesRoko P A Nikolic, Eldad Ben-Chetrit, Marvin J Fritzler, et al.
Pageof 28